News
Lilly buys into MiNA's protein-boosting RNA tech in $1.25bn ...
UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to